These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3942882)

  • 1. Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat.
    Kamata K; Wilson RL; Alloway KD; Rebec GV
    Brain Res; 1986 Jan; 362(2):331-8. PubMed ID: 3942882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo voltammetry with electrodes that discriminate between dopamine and ascorbate.
    Ewing AG; Wightman RM; Dayton MA
    Brain Res; 1982 Oct; 249(2):361-70. PubMed ID: 6814706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum.
    Oh C; Gardiner TW; Rebec GV
    Brain Res; 1989 Feb; 480(1-2):184-9. PubMed ID: 2565749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference by DOPAC and ascorbate during attempts to measure drug-induced changes in neostriatal dopamine with Nafion-coated, carbon-fiber electrodes.
    Wiedemann DJ; Basse-Tomusk A; Wilson RL; Rebec GV; Wightman RM
    J Neurosci Methods; 1990 Oct; 35(1):9-18. PubMed ID: 2148961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum.
    Wilson RL; Kamata K; Bigelow JC; Rebec GV; Wightman RM
    Brain Res; 1986 Apr; 370(2):393-6. PubMed ID: 3518863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats.
    Yount SE; Kraft ME; Pierce RC; Langley PE; Rebec GV
    Life Sci; 1991; 49(17):1237-44. PubMed ID: 1943438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats.
    Pierce RC; Rebec GV
    Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum.
    Basse-Tomusk A; Rebec GV
    Pharmacol Biochem Behav; 1990 Jan; 35(1):55-60. PubMed ID: 2315370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats.
    Miele M; Mura MA; Enrico P; Esposito G; Serra PA; Migheli R; Zangani D; Miele E; Desole MS
    Br J Pharmacol; 2000 Feb; 129(3):582-8. PubMed ID: 10711358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ascorbic acid pretreatment on amphetamine-induced dopamine depletion in male and female mice.
    Gifford JJ; Wagner GC
    Neuroreport; 2020 Jul; 31(10):737-740. PubMed ID: 32459674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex.
    Heikkila RE; Orlansky H; Mytilineou C; Cohen G
    J Pharmacol Exp Ther; 1975 Jul; 194(1):47-56. PubMed ID: 1151755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shift from inhibition to excitation in the neostriatum but not in the nucleus accumbens following long-term amphetamine.
    Alloway KD; Rebec GV
    Brain Res; 1983 Aug; 273(1):71-9. PubMed ID: 6616234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral neostriatal kainate, but not 6-OHDA, lesions block dopamine agonist-induced ascorbate release in the neostriatum of freely moving rats.
    Pierce RC; Miller DW; Reising DB; Rebec GV
    Brain Res; 1992 Nov; 597(1):138-43. PubMed ID: 1477726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemistry in vivo: monitoring dopamine release in the brain of the conscious, freely moving rat.
    Lane RF; Blaha CD; Hari SP
    Brain Res Bull; 1987 Jul; 19(1):19-27. PubMed ID: 3651839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of D- and L-amphetamine on dopamine metabolism and ascorbic acid levels in nucleus accumbens and olfactory tubercle as studied by in vivo differential pulse voltammetry.
    Louilot A; Gonon F; Buda M; Simon H; Le Moal M; Pujol JF
    Brain Res; 1985 Jun; 336(2):253-63. PubMed ID: 4005584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral dopamine depletions attenuate the response of striatal neurons to systemic amphetamine in both hemispheres.
    Basse-Tomusk AE; Rebec GV
    Neuroscience; 1985 Dec; 16(4):845-50. PubMed ID: 4094695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltammetry in the striatum of chronic freely moving rats: detection of catechols and ascorbic acid.
    Gonon F; Buda M; Cespuglio R; Jouvet M; Pujol JF
    Brain Res; 1981 Oct; 223(1):69-80. PubMed ID: 7284811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain dialysis in conscious rats confirms in vivo electrochemical evidence that dopaminergic stimulation releases ascorbate.
    Clemens JA; Phebus LA
    Life Sci; 1984 Aug; 35(6):671-7. PubMed ID: 6748865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral, intranigral infusions of amphetamine produce differential, bilateral changes in unit activity and extracellular levels of ascorbate in the neostriatum of the rat.
    Wilson RL; Kamata K; Wightman RM; Rebec GV
    Brain Res; 1986 Oct; 384(2):342-7. PubMed ID: 3779385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular ascorbic acid increases in striatum following systemic amphetamine.
    Salamone JD; Hamby LS; Neill DB; Justice JB
    Pharmacol Biochem Behav; 1984 Apr; 20(4):609-12. PubMed ID: 6728876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.